What does this video actually claim?
@koitsu (Enzo) posted a brief TikTok suggesting viewers "just take reta" alongside hashtags for bodybuilding and peptides. "Reta" refers to retatrutide, an experimental triple hormone receptor agonist that targets GIP, GLP-1, and glucagon receptors.
The video's brevity is problematic. There's no dosing information, no discussion of side effects, and no mention that retatrutide isn't FDA-approved for any indication. For a compound this potent, that's irresponsible.
Is retatrutide actually effective for muscle building?
Retatrutide shows promise for weight loss, but calling it a muscle-building peptide misses the point entirely. The Phase 2 TRIUMPH-1 trial (Rosenstock et al., NEJM, 2023) found 24.2% weight loss with the 12mg dose at 48 weeks.
That's dramatic weight loss, not muscle gain. The glucagon receptor activation might help preserve lean mass during weight loss compared to other GLP-1 drugs, but we don't have solid body composition data yet.
The muscle-building claims likely stem from retatrutide's ability to help people lose fat while potentially maintaining more muscle than traditional dieting. That's not the same as building new muscle tissue.
What are the real risks here?
Enzo's casual "just take reta" approach ignores some serious safety concerns. Retatrutide caused gastrointestinal side effects in 80% of participants in TRIUMPH-1, with 13% discontinuing due to adverse events.
The compound isn't approved anywhere in the world yet. People buying "retatrutide" online are getting unregulated products of unknown purity and potency. That's a significant risk for compounds this powerful.
The dosing matters enormously. TRIUMPH-1 used escalating doses from 1mg to 12mg over months. Starting too high or escalating too quickly can cause severe nausea, vomiting, and dehydration.
What should fitness enthusiasts actually know?
Retatrutide might eventually have a place in body composition optimization, but it's not ready for general use. The research pipeline suggests FDA approval could come in 2026 at the earliest.
For people interested in peptides for muscle building, there's better evidence for growth hormone secretagogues like ipamorelin or CJC-1295. These target growth hormone pathways more directly than retatrutide's metabolic approach.
If you're considering any peptide therapy, work with a qualified provider who can monitor your response and adjust dosing appropriately. The "just take it" mentality can lead to serious problems with these powerful compounds.